Next Bt Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 12, 2021 at 03:24 am EST
Share
Next Bt Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 19,291.25 million compared to KRW 14,192.19 million a year ago. Net loss was KRW 1,026.92 million compared to KRW 7,736.71 million a year ago. Basic loss per share from continuing operations was KRW 12 compared to KRW 93 a year ago. Diluted loss per share from continuing operations was KRW 12 compared to KRW 93 a year ago. Basic loss per share was KRW 12 compared to KRW 93 a year ago.
For the nine months, sales was KRW 59,275.36 million compared to KRW 42,587.86 million a year ago. Net loss was KRW 13,670.99 million compared to KRW 5,145.58 million a year ago. Basic loss per share from continuing operations was KRW 156 compared to KRW 74 a year ago. Diluted loss per share from continuing operations was KRW 156 compared to KRW 74 a year ago. Basic loss per share was KRW 156 compared to KRW 74 a year ago.
BL PharmTech Corp, formerly Next BT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of health foods. The Company operates its business through four segments. The Health Functional Food Business segment is engaged in the manufacture and sale of products such as red ginsengs, diet foods and vitamins. The Cosmetics Business segment is engaged in the manufacture and sale of anti-aging skincare products and, among others. The Diagnostic and Medical Business segment is engaged in the manufacture and sale of diagnostic kits and other products. The Other segment is engaged in the distribution of health foods and other products.
BL PHARMTECH CORP. 
